These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 35691594

  • 1. The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats.
    Patsenker E, Thangapandi VR, Knittelfelder O, Palladini A, Hefti M, Beil-Wagner J, Rogler G, Buch T, Shevchenko A, Hampe J, Stickel F.
    J Nutr Biochem; 2022 Oct; 108():109081. PubMed ID: 35691594
    [Abstract] [Full Text] [Related]

  • 2. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
    Kim HS, Xiao X, Byun J, Jun G, DeSantis SM, Chen H, Thrift AP, El-Serag HB, Kanwal F, Amos CI.
    JAMA Netw Open; 2022 Oct 03; 5(10):e2234221. PubMed ID: 36190732
    [Abstract] [Full Text] [Related]

  • 3. PNPLA3 I148M polymorphism and progressive liver disease.
    Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S, Valenti L.
    World J Gastroenterol; 2013 Nov 07; 19(41):6969-78. PubMed ID: 24222941
    [Abstract] [Full Text] [Related]

  • 4. Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals.
    Su H, Haque M, Becker S, Edlund K, Duda J, Wang Q, Reißing J, Marschall HU, Candels LS, Mohamed M, Sjöland W, Liao L, Drexler SA, Strowig T, Rahnenführer J, Hengstler JG, Hatting M, Trautwein C.
    Liver Int; 2023 Aug 07; 43(8):1699-1713. PubMed ID: 37073116
    [Abstract] [Full Text] [Related]

  • 5. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
    Nomair AM, Kandil LS, Nomeir HM, Kandil NS.
    Asian Pac J Cancer Prev; 2021 Oct 01; 22(10):3317-3326. PubMed ID: 34711009
    [Abstract] [Full Text] [Related]

  • 6. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S.
    World J Gastroenterol; 2012 Jun 14; 18(22):2813-20. PubMed ID: 22719190
    [Abstract] [Full Text] [Related]

  • 7. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
    Wang LQ, Guo WH, Guo ZW, Qin P, Zhang R, Zhu XM, Liu DW.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec 10; 39(12):1611-1616. PubMed ID: 30572387
    [Abstract] [Full Text] [Related]

  • 8. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.
    Cherubini A, Ostadreza M, Jamialahmadi O, Pelusi S, Rrapaj E, Casirati E, Passignani G, Norouziesfahani M, Sinopoli E, Baselli G, Meda C, Dongiovanni P, Dondossola D, Youngson N, Tourna A, Chokshi S, Bugianesi E, EPIDEMIC Study Investigators, Della Torre S, Prati D, Romeo S, Valenti L.
    Nat Med; 2023 Oct 10; 29(10):2643-2655. PubMed ID: 37749332
    [Abstract] [Full Text] [Related]

  • 9. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis.
    Banini BA, Kumar DP, Cazanave S, Seneshaw M, Mirshahi F, Santhekadur PK, Wang L, Guan HP, Oseini AM, Alonso C, Bedossa P, Koduru SV, Min HK, Sanyal AJ.
    Hepatology; 2021 Apr 10; 73(4):1290-1306. PubMed ID: 33131062
    [Abstract] [Full Text] [Related]

  • 10. Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.
    Ericson E, Bergenholm L, Andréasson AC, Dix CI, Knöchel J, Hansson SF, Lee R, Schumi J, Antonsson M, Fjellström O, Nasr P, Liljeblad M, Carlsson B, Kechagias S, Lindén D, Ekstedt M.
    Hepatol Commun; 2022 Oct 10; 6(10):2689-2701. PubMed ID: 35833455
    [Abstract] [Full Text] [Related]

  • 11. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression.
    Volkert I, Fromme M, Schneider C, Candels L, Lindhauer C, Su H, Thorhauge K, Pons M, Mohamed MR, Schneider KM, Strnad P, Trautwein C.
    Hepatology; 2024 Apr 01; 79(4):898-911. PubMed ID: 37625151
    [Abstract] [Full Text] [Related]

  • 12. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
    Grimaudo S, Pipitone RM, Pennisi G, Celsa C, Cammà C, Di Marco V, Barcellona MR, Boemi R, Enea M, Giannetti A, Spatola F, Marchesini G, Craxì A, Petta S.
    Clin Gastroenterol Hepatol; 2020 Apr 01; 18(4):935-944.e3. PubMed ID: 31419571
    [Abstract] [Full Text] [Related]

  • 13. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
    Stickel F, Buch S, Nischalke HD, Weiss KH, Gotthardt D, Fischer J, Rosendahl J, Marot A, Elamly M, Casper M, Lammert F, McQuillin A, Zopf S, Spengler U, Marhenke S, Kirstein MM, Vogel A, Eyer F, von Felden J, Wege H, Buch T, Schafmayer C, Braun F, Deltenre P, Berg T, Morgan MY, Hampe J.
    Am J Gastroenterol; 2018 Oct 01; 113(10):1475-1483. PubMed ID: 29535416
    [Abstract] [Full Text] [Related]

  • 14. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.
    Valenti L, Dongiovanni P, Ginanni Corradini S, Burza MA, Romeo S.
    Dig Liver Dis; 2013 Aug 01; 45(8):619-24. PubMed ID: 23333103
    [Abstract] [Full Text] [Related]

  • 15. PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.
    Friedrich K, Wannhoff A, Kattner S, Brune M, Hov JR, Weiss KH, Antoni C, Dollinger M, Neumann-Haefelin C, Seufferlein T, Schemmer P, Schirmacher P, Stremmel W, Gotthardt DN.
    J Gastroenterol Hepatol; 2014 Aug 01; 29(7):1477-84. PubMed ID: 25273282
    [Abstract] [Full Text] [Related]

  • 16. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.
    Li JZ, Huang Y, Karaman R, Ivanova PT, Brown HA, Roddy T, Castro-Perez J, Cohen JC, Hobbs HH.
    J Clin Invest; 2012 Nov 01; 122(11):4130-44. PubMed ID: 23023705
    [Abstract] [Full Text] [Related]

  • 17. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
    Lindén D, Ahnmark A, Pingitore P, Ciociola E, Ahlstedt I, Andréasson AC, Sasidharan K, Madeyski-Bengtson K, Zurek M, Mancina RM, Lindblom A, Bjursell M, Böttcher G, Ståhlman M, Bohlooly-Y M, Haynes WG, Carlsson B, Graham M, Lee R, Murray S, Valenti L, Bhanot S, Åkerblad P, Romeo S.
    Mol Metab; 2019 Apr 01; 22():49-61. PubMed ID: 30772256
    [Abstract] [Full Text] [Related]

  • 18. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.
    Burza MA, Molinaro A, Attilia ML, Rotondo C, Attilia F, Ceccanti M, Ferri F, Maldarelli F, Maffongelli A, De Santis A, Attili AF, Romeo S, Ginanni Corradini S.
    Liver Int; 2014 Apr 01; 34(4):514-20. PubMed ID: 24102786
    [Abstract] [Full Text] [Related]

  • 19. PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis.
    Urias E, Tedesco NR, Burkholder DA, Moran IJ, Miller MJ, Jasty VSJ, Patil S, Zoellner S, Wijarnpreecha K, Chen VL.
    Hepatol Commun; 2024 Jun 01; 8(6):. PubMed ID: 38780253
    [Abstract] [Full Text] [Related]

  • 20. The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu.
    Nischalke HD, Lutz P, Bartok E, Krämer B, Langhans B, Frizler R, Berg T, Hampe J, Buch S, Datz C, Stickel F, Hartmann G, Strassburg CP, Nattermann J, Spengler U.
    J Mol Med (Berl); 2019 Nov 01; 97(11):1589-1600. PubMed ID: 31637480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.